SNUS Insider Trading Activity and SEC Form 4 Filings
SNUS insider trading summary
No open-market insider purchases or sales of Sonus Pharmaceuticals Inc (SNUS) have been reported on SEC Form 4 in the past 12 months.
Latest SNUS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 18, 2007 | Robert E Ivy | Director | Sell | $55K (10,000 @ $5.46) |
| May 17, 2007 | Robert E Ivy | Director | Sell | $54K (10,000 @ $5.36) |
| May 16, 2007 | Robert E Ivy | Director | Sell | $54K (10,000 @ $5.40) |
| Nov 16, 2006 | George W Dunbar Jr | Director | Buy | $10K (1,750 @ $5.45) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.